Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
Phase 1
Recruiting
- Conditions
- Head and Neck Cancer
- Interventions
- First Posted Date
- 2024-07-10
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT06494189
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Efficacy of Fullerene in Preventing Radiation Dermatitis in Patients With Head and Neck Cancer .
Not Applicable
Not yet recruiting
- Conditions
- Radiation Dermatitis
- Interventions
- Other: Fullerene cream
- First Posted Date
- 2024-07-03
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 132
- Registration Number
- NCT06484166
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
Phase 2
Recruiting
- Conditions
- Locally Advanced Thyroid Gland Carcinoma
- Interventions
- First Posted Date
- 2024-07-01
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 75
- Registration Number
- NCT06482086
- Locations
- 🇨🇳
West China hospital, Chengdu, Sichuan, China
Physical Function and Mental Health in Cancer Survivors
Completed
- Conditions
- CancerDepressive SymptomsSedentary BehaviorSurvivorship
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 2932
- Registration Number
- NCT06439316
Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma
Phase 2
Recruiting
- Conditions
- Cholangiocarcinoma
- Interventions
- Combination Product: Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil
- First Posted Date
- 2024-06-03
- Last Posted Date
- 2025-05-07
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 51
- Registration Number
- NCT06438822
- Locations
- 🇨🇳
West China Hospital, Sichuan University, Chengdu, Sichuan, China
Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
- First Posted Date
- 2024-05-31
- Last Posted Date
- 2024-06-03
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 200
- Registration Number
- NCT06437158
- Locations
- 🇨🇳
West China Hospital of Sichuan University, Chengdu, Sichuan, China
Sintilimab Combined With LDRT for Neoadjuvant Treatment of Locally Advanced dMMR/MSI-H Gastric Cancer
Phase 1
Not yet recruiting
- Conditions
- Gastric Cancer
- Interventions
- Drug: sintiliman plus LDRT
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2024-05-23
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 45
- Registration Number
- NCT06426654
Fruquintinib Plus S-1 and Raltitrexed (RSF) for MCRC
Phase 2
Recruiting
- Conditions
- FruquintinibRaltitrexedS-1
- Interventions
- First Posted Date
- 2024-05-23
- Last Posted Date
- 2025-01-22
- Lead Sponsor
- Meng Qiu
- Target Recruit Count
- 66
- Registration Number
- NCT06427005
- Locations
- 🇨🇳
Sichuan University West China Hospital, Chengdu, Sichuan, China
🇨🇳West China Hospital, Sichuan University, Chengdu, Sichuan, China
Hypertension Longitudinal Data Platform in Tianjin
Completed
- Conditions
- Hypertension
- Interventions
- Other: No intervention
- First Posted Date
- 2024-05-16
- Last Posted Date
- 2024-05-17
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 1172280
- Registration Number
- NCT06415071
- Locations
- 🇨🇳
The West China Hospital of Sichuan university, Chengdu, Sichuan, China
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
Not Applicable
Recruiting
- Conditions
- Liver Cancer
- Interventions
- Device: TEAS groupDevice: sham group
- First Posted Date
- 2024-05-09
- Last Posted Date
- 2024-05-09
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 524
- Registration Number
- NCT06406244
- Locations
- 🇨🇳
West China Hospital, Chengdu, China
© Copyright 2025. All Rights Reserved by MedPath